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Exosomes Objectives: Cardiovascular disorders are the major health problem and the leading cause of death and disability in both industrialized and developing nations. Myocardial ischemia/reperfusion (I/R) leads to cardiomyocyte injury, including apoptosis and hypertrophy.
Methods: Here we investigated the effects of the derivatives, exosomes (ADSC-exosome), from adipose-derived stem cells (ADSCs) on cardiac I/R mice and the underlying mechanisms.
Results: ADSC-exosome significantly attenuated I/R-induced reactive oxygen species production. ADSC-exosome also decreased cardiomyocyte apoptosis and hypertrophy by terminal deoxynucleotidyl transferase dUTP nick end labeling and wheat germ agglutinin staining, respectively. Moreover, the expression of the apoptosis-related proteins, P-p53 and PUMA (p53 upregulated modulator of apoptosis), and the hypertrophy-related proteins, Ets-1 (v-ets erythroblastosis virus E26 oncogene homolog 1) and atrial natriuretic peptide, was significantly reduced in cardiomyocytes of I/R mice with ADSC-exosome treatment. H9c2 cardiomyocytes increased cell apoptosis and hypertrophy under H 2 O 2 environment. Furthermore, ADSC-exosome protected H9c2 cardiomyocytes from H 2 O 2 -induced damages by decreasing the number of apoptosis and hypertrophy in vitro. In addition, ADSC-exosome treatment decreased H 2 O 2 -induced PUMA and Ets-1 expression.
Conclusions: Based on these findings, ADSC-exosome could serve as an effective therapy for the prevention of I/R-induced cardiac injury through the decrease of apoptosis and hypertrophy.
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Finite-Element
Methods: Aortic tissue samples from 64 patients with an AAA that had been imaged with computed tomography angiography (CTA) before surgery were collected from the Stockholm AAA Biobank, separated into intima/media and adventitia wall layers, and analyzed with Affymetrix HTA 2.0 microarrays. The aortas were segmented from the CTAs into three-dimensional digital models, which were then subjected to finite-element analysis (FEA) without informing the software (VASCOPS A4clinics Research Edition) about age, gender, family history, or blood pressure. Peak wall rupture index (PWRI), derived from the FEA, was used as a marker of biomechanical rupture risk. Differential gene expression, adjusted for age and gender, was studied with R software. Enriched gene ontology processes were examined for annotated transcripts with the GOrilla and REVIGO online tools.
Results: No transcript was significantly associated with PWRI after 5% false discovery rate correction was performed, in either media or adventitia. However, there were 1203 and 872 transcripts associated with PWRI at a nominal P of <.05 in media and adventitia, respectively. Analysis of enriched biological processes using the entire annotated transcript list ranked by fold-change revealed that extracellular matrix and structure organization in the media and nucleic acid metabolism and RNA metabolism in the adventitia were the most enriched biological processes in aneurysms with high PWRI.
Conclusions: These results suggest that biomechanical rupture risk associates with expression of extracellular matrix genes as well as the level of bulk gene activity. Objectives: Nanotopographic surface engineering can produce a vascular graft surface with the potential to enhance endothelial cell (EC) adhesion. Our aim was to investigate EC response to different nanopit topographies compared to normal, focusing on cell adherence.
Methods: Two nanopit topographies were studied: the first was a regular symmetric square arrangement (SQ) of diameter 120 nm, center-center spacing of 300 nm, and depth of 100 nm, and the second was a nonsymmetric square surface (NSQ), which provides pits of similar dimensions but with an offset of 650 nm. The control was smooth topography. Human umbilical vein ECs (HUVECs) were seeded on these substrates and cultured for 5 days. To assess and quantify adherence, In-Cell Western was used to quantify P-myosin and VE-cadherin (cell adhesion proteins). Scanning electron microscopy was used to image the HUVECs and graft surfaces by measuring cell intensity.
Results: HUVEC adhesion was present at 5 days on both topographies with a statistically significant upregulation of P-myosin on the NSQ substrate (P < .05) compared with smooth topography. Increased cell counts were found on NSQ, indicating that cell adherence is optimal with this topography (P < .05). Cell intensity measurements were highest with NSQ, showing this topography promotes cell growth. VE-cadherin was upregulated over SQ, and this correlates with a reduced cell count (P < .05). Scanning electron microscopy images show the HUVECs interacting with the different nanopits by way of filopodia.
Conclusions: EC adhesion can be increased in vitro by modulating surface topography with nanopits but subtle changes, such as an offset of 650 nm, can deliver further significant improvement on cell adherence and proliferation. This illustrates the importance of subtle changes in the nanoscale, which can bring around profound changes in cell behavior. Further assessment of the NSQ topography with regards to endothelial cell function is planned. By approximating to normal blood vessel surface, nanotopography, especially nanopits, promises to enhance prosthetic graft function by increasing endothelial adhesion. Objectives: We report the outcomes in the management of postdissection aneurysms of the aortic arch and thoracoabdominal aortic aneurysm (TAAA) segment treated with fenestrated and branched (complex) endografts.
Methods: Between October 2011 and January 2017, all patients with chronic postdissecting aneurysms >55 mm deemed unfit for open surgery after multidisciplinary evaluation and treated by complex endografting were included. When appropriate, staged management strategies, including left subclavian artery revascularization, thoracic endografting, dissection flap fenestration, or tear enlargement, and other endovascular procedures were performed prior to the complex endovascular repair. During follow-up, the outcomes data were collected according to the reporting standards: technical success, endoleaks, target vessel patency, aneurysm diameter, major and minor complications, reinterventions, and mortality. Data were prospectively collected in an electronic database.
Results: The cohort comprised 39 patients with a median age of 64 years (37-84 years). Forty-two procedures were performed: 18 arch repairs with inner branched endografts (1 to 3 branches) and 24 TAAA repairs with fenestrated or branched endografts. Three patients had both arch and TAAA repairs during the study period. Median time between dissection diagnosis and complex aortic repair was 5 years (0.25-33 years). Staged procedures were performed in 74% (29 of 39) of patients. Technical success rate was 93% (39 of 42). Median procedure time was 240 minutes (100-510 minutes), and median x-ray time 41.5 minutes (16-225 minutes). Early (<30-day) mortality was 2.5%, and in-hospital mortality was 5%. Spinal cord ischemia was observed in three patients after TAAA repair: one recovered completely and one died. One minor stroke and one transient ischemic attack were observed (5%). Two patients required transient dialysis. Six early reinterventions (14%) were performed, 3 for access complications, 2 for acute hemorrhage, and 1 to treat a type II endoleak. The median follow-up was 34.5 months (0-153 months). Three patients died (nonaneurysm related) during follow-up. Seven patients (18%) underwent late reinterventions, two in the arch group and five in the TAAA group. All target vessels remained patent during follow-up.
Conclusions: Complex endovascular repair of postdissecting aneurysms is a safe alternative to open repair in patients deemed unfit for open surgery. This technique is associated with a high rate of secondary procedures, and cautious follow-up is thus required.
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